Species: Mu
Applications: WB, ELISA, ICC/IF, KO
Host: Sheep Polyclonal
Species: Hu, Mu
Applications: ELISA, Flow, CyTOF-ready, ICC/IF, KO
Host: Rat Monoclonal
Species: Mu
Applications: WB
Host: Rat Monoclonal
Species: Hu
Applications: ELISA
Host: Monoclonal
Species: Hu
Applications: ELISA
Species: Hu
Applications: ELISA
Species: Hu
Applications: ELISA
Species: Hu
Applications: WB
Species: Mu
Applications: Bioactivity
Species: Hu
Applications: Bioactivity
Species: Hu
Applications: Bioactivity
Description
TREM2 (Triggering Receptor Expressed on Myeloid cells-2) is
a 35 kDa molecular weight type I transmembrane member of the TREM family and Ig
superfamily . Mature human TREM2 consists of a 156 amino acid (aa)
extracellular domain (ECD) with one V-type Ig-like domain, a 21 aa
transmembrane (TM) domain, and a 35 aa cytoplasmic tail. Within the ECD, human
TREM2 shares 73% and 74% aa sequence identity with mouse and rat TREM2,
respectively. Two closely related transcripts were reported in mouse and
designated TREM2a and TREM2b. Soluble forms of the TREM2 ECD are generated
by alternative splicing or proteolytic cleavage, and the cytoplasmic domain can
be liberated by gamma-Secretase mediated intramembrane cleavage. It is a pattern
recognition receptor that binds anionic ligands. A positively charged lysine
within the transmembrane segment allows association with the signal adapter
protein, DAP12 to deliver an activating signal that plays a role in both innate
and adaptive immune responses, including inhibition of macrophage activation.
TREM2 is expressed on macrophages, immature myeloid dendritic cells,
osteoclasts, microglia, and adipocytes. It promotes the differentiation and
function of osteoclasts, the production of inflammatory cytokines by
adipocytes, insulin resistance, and the phagocytic clearance of bacteria. In
the CNS, TREM2 binds to ApoE, ApoA1, and ApoB and mediates the clearance of
apoptotic neurons, amyloid plaques, and cell debris following demyelination.
TREM2 also interacts with and modifies signaling through Plexin A1 on
dendritic cells and osteoclasts. Mutations in TREM2 or DAP12 are associated
with the development of Alzheimer's disease and Nasu-Hakola disease (NHD/PLOSL)
which is characterized by presenile dementia and bone cysts. Soluble TREM2 is
elevated in cerebrospinal fluid of patients with active multiple sclerosis
(MS), and TREM2 blockade exacerbates disease symptoms in the experimental EAE
model of MS.
Bioinformatics
| Uniprot |
|
| Product By Gene ID |
54209 |
| Alternate Names |
- PLOSL2
- TREM2
- TREM-2
- Trem2a
- Trem2b
- Trem2c
- TREM-2triggering receptor expressed on myeloid cells 2a
- Triggering receptor expressed on monocytes 2
- triggering receptor expressed on myeloid cells 2
|